{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T11:25:45Z","timestamp":1764242745704,"version":"3.46.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Center of Excellence (COE) for HIV care , National Aids Control Organization (NACO) & Uttar Pradesh State AIDS control society","award":["(Scheme No. 4080)"],"award-info":[{"award-number":["(Scheme No. 4080)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11790-w","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T06:16:55Z","timestamp":1764224215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of different methods for the detection of HLA-B* 57:01 allele in people living with HIV in Eastern Uttar Pradesh, India"],"prefix":"10.1186","volume":"25","author":[{"given":"Tulika Kumari","family":"Rai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaya","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumari","family":"Priyanka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhilasha","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shweta","family":"Srivastva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"11790_CR1","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s12098-016-2044-z","volume":"83","author":"J Chakravarty","year":"2016","unstructured":"Chakravarty J, Sharma S, Johri A, Chourasia A, Sundar S. Clinical abacavir hypersensitivity reaction among children in India. Indian J Pediatr. 2016;83:855\u20138.","journal-title":"Indian J Pediatr"},{"key":"11790_CR2","unstructured":"National AIDS Control Organization. National Guidelines for HIV Care and Treatment. 2021. In.: New Delhi: NACO, Ministry of Health and Family Welfare, Government of India. 2021. https:\/\/naco.gov.in\/sites\/default\/files\/National_Guidelines_for_HIV_Care_and_Treatment_2021.pdf."},{"key":"11790_CR3","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2165\/00003495-200060020-00015","volume":"60","author":"PS Hervey","year":"2000","unstructured":"Hervey PS, Perry CM. Abacavir: a review of its clinical potential in patients with HIV infection. Drugs. 2000;60:447\u201379.","journal-title":"Drugs"},{"issue":"9308","key":"11790_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0140-6736(02)07873-X","volume":"359","author":"S Mallal","year":"2002","unstructured":"Mallal S, Nolan D, Witt C, Masel G, Martin A, Moore C, Sayer D, Castley A, Mamotte C, Maxwell D. Association between presence of HLA-B* 5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet. 2002;359(9308):727\u201332.","journal-title":"Lancet"},{"issue":"6","key":"11790_CR5","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.immuni.2008.04.020","volume":"28","author":"D Chessman","year":"2008","unstructured":"Chessman D, Kostenko L, Lethborg T, Purcell AW, Williamson NA, Chen Z, et al. Human leukocyte antigen class I-restricted activation of CD8\u2009+\u2009T cells provides the immunogenetic basis of a systemic drug hypersensitivity. Immunity. 2008;28(6):822\u201332.","journal-title":"Immunity"},{"key":"11790_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cegh.2022.101181","volume":"18","author":"A Gautam","year":"2022","unstructured":"Gautam A, Chakravarty J, Chourasia A, Sharma S, Sarkar T, Das P. Prevalence of HLA-B* 57: 01 allele in HIV-positive and HIV-negative population of Eastern India: an epidemiological study. Clin Epidemiol Glob Health. 2022;18:101181.","journal-title":"Clin Epidemiol Glob Health"},{"issue":"6","key":"11790_CR7","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1086\/591184","volume":"198","author":"S Colombo","year":"2008","unstructured":"Colombo S, Rauch A, Rotger M, Fellay J, Martinez R, Fux C, et al. The HCP5 single-nucleotide polymorphism: a simple screening tool for prediction of hypersensitivity reaction to abacavir. J Infect Dis. 2008;198(6):864\u20137.","journal-title":"J Infect Dis"},{"issue":"15\u201316","key":"11790_CR8","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/j.cca.2011.04.010","volume":"412","author":"CA Galv\u00e1n","year":"2011","unstructured":"Galv\u00e1n CA, Elbarcha OC, Fern\u00e1ndez EJ, Beltramo DM, Soria NW. Rapid HCP5 single-nucleotide polymorphism genotyping: a simple allele-specific PCR method for prediction of hypersensitivity reaction to abacavir. Clin Chim Acta. 2011;412(15\u201316):1382\u20134.","journal-title":"Clin Chim Acta"},{"issue":"10","key":"11790_CR9","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/ng1885","volume":"38","author":"PI De Bakker","year":"2006","unstructured":"De Bakker PI, McVean G, Sabeti PC, Miretti MM, Green T, Marchini J, Ke X, Monsuur AJ, Whittaker P, Delgado M. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet. 2006;38(10):1166\u201372.","journal-title":"Nat Genet"},{"issue":"6","key":"11790_CR10","doi-asserted-by":"publisher","first-page":"809","DOI":"10.2217\/pgs.11.31","volume":"12","author":"F Sanchez-Giron","year":"2011","unstructured":"Sanchez-Giron F, Villegas-Torres B, Jaramillo-Villafuerte K, Silva-Zolezzi I, Fernandez-Lopez JC, Jimenez-Sanchez G, Carnevale A. Association of the genetic marker for abacavir hypersensitivity HLA-B* 5701 with HCP5 rs2395029 in Mexican mestizos. Pharmacogenomics. 2011;12(6):809\u201314.","journal-title":"Pharmacogenomics"},{"issue":"3","key":"11790_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/FPC.0000000000000421","volume":"31","author":"P Zubiaur","year":"2021","unstructured":"Zubiaur P, Saiz-Rodr\u00edguez M, Villapalos-Garc\u00eda G, Navares-G\u00f3mez M, Koller D, Abad-Santos F. HCP5 rs2395029 is a rapid and inexpensive alternative to HLA-B* 57: 01 genotyping to predict abacavir hypersensitivity reaction in Spain. Pharmacogenet Genomics. 2021;31(3):53\u20139.","journal-title":"Pharmacogenet Genomics"},{"key":"11790_CR12","first-page":"A280","volume":"260","author":"A Shukla","year":"2015","unstructured":"Shukla A, Raut A, Choudhary S. Optimization of PCR DNA sequencing method for SNP detection in abacavir sensitivity gene. DNA. 2015;260:A280.","journal-title":"DNA"},{"issue":"2","key":"11790_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/ajcp\/69.2.103","volume":"69","author":"PI Terasaki","year":"1978","unstructured":"Terasaki PI, Bernoco D, Park MS, Ozturk G, Iwaki Y. Microdroplet testing for HLA-A,-B,-C, and-D antigens: the Philip Levine award lecture. Am J Clin Pathol. 1978;69(2):103\u201320.","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"11790_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1399-0039.2011.01649.x","volume":"78","author":"L Kostenko","year":"2011","unstructured":"Kostenko L, Kjer-Nielsen L, Nicholson I, Hudson F, Lucas A, Foley B, Chen K, Lynch K, Nguyen J, Wu A. Rapid screening for the detection of HLA\u2010B57 and HLA\u2010B58 in prevention of drug hypersensitivity. Tissue Antigens. 2011;78(1):11\u201320.","journal-title":"Tissue Antigens"},{"issue":"5","key":"11790_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/01.fpc.0000197468.16126.cd","volume":"16","author":"AM Martin","year":"2006","unstructured":"Martin AM, Krueger R, Almeida CA, Nolan D, Phillips E, Mallal S. A sensitive and rapid alternative to HLA typing as a genetic screening test for abacavir hypersensitivity syndrome. Pharmacogenet Genomics. 2006;16(5):353\u20137.","journal-title":"Pharmacogenet Genomics"},{"issue":"5","key":"11790_CR16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1399-0039.1993.tb02191.x","volume":"42","author":"J Ng","year":"1993","unstructured":"Ng J, Hurley CK, Baxter-Lowe LA, Chopek M, Coppo PA, Hegland J, et al. Large-scale oligonucleotide typing for HLA-DRB1\/3\/4 and HLA-DQB1 is highly accurate, specific, and reliable. Tissue Antigens. 1993;42(5):473\u20139.","journal-title":"Tissue Antigens"},{"issue":"6","key":"11790_CR17","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1399-0039.2005.00401.x","volume":"65","author":"A Martin","year":"2005","unstructured":"Martin A, Nolan D, Mallal S. HLA-B* 5701 typing by sequence\u2010specific amplification: validation and comparison with sequence\u2010based typing. Tissue Antigens. 2005;65(6):571\u20134.","journal-title":"Tissue Antigens"},{"issue":"7","key":"11790_CR18","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1177\/135965350701200708","volume":"12","author":"E Hammond","year":"2007","unstructured":"Hammond E, Almeida C, Mamotte C, Nolan D, Phillips E, Schollaardt TA, et al. External quality assessment of HLA-B* 5701 reporting: an international multicentre survey. Antivir Ther. 2007;12(7):1027\u201332.","journal-title":"Antivir Ther"},{"issue":"4","key":"11790_CR19","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2217\/pgs.10.208","volume":"12","author":"C Dello Russo","year":"2011","unstructured":"Dello Russo C, Lisi L, Lofaro A, Di Giambenedetto S, Federico B, Madeddu G, et al. Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B* 57: 01 detection by real-time PCR. Pharmacogenomics. 2011;12(4):567\u201376.","journal-title":"Pharmacogenomics"},{"issue":"5","key":"11790_CR20","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1034\/j.1399-0039.2003.00062.x","volume":"61","author":"D Middleton","year":"2003","unstructured":"Middleton D, Menchaca L, Rood H, Komerofsky R. New allele frequency database. Tissue Antigens. 2003;61(5):403\u20137.","journal-title":"Tissue Antigens"},{"issue":"21","key":"11790_CR21","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1002\/elps.201000283","volume":"31","author":"E Giardina","year":"2010","unstructured":"Giardina E, Stocchi L, Cuzzola VF, Zampatti S, Gambardella S, Patrizi MP, et al. A fluorescence-based sequence-specific primer PCR for the screening of HLA-B* 57:01. Electrophoresis. 2010;31(21):3525\u201330.","journal-title":"Electrophoresis"},{"issue":"1","key":"11790_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1399-0039.2007.00840.x","volume":"70","author":"E Hammond","year":"2007","unstructured":"Hammond E, Mamotte C, Nolan D, Mallal S. HLA-B* 5701 typing: evaluation of an allele\u2010specific polymerase chain reaction melting assay. Tissue Antigens. 2007;70(1):58\u201361.","journal-title":"Tissue Antigens"},{"issue":"8","key":"11790_CR23","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1093\/jac\/dkq204","volume":"65","author":"S Rodr\u00edguez-N\u00f3voa","year":"2010","unstructured":"Rodr\u00edguez-N\u00f3voa S, Cuenca L, Morello J, C\u00f3rdoba M, Blanco F, Jim\u00e9nez-N\u00e1cher I, et al. Use of the HCP5 single nucleotide polymorphism to predict hypersensitivity reactions to abacavir: correlation with HLA-B* 5701. J Antimicrob Chemother. 2010;65(8):1567\u20139.","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"11790_CR24","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1089\/gtmb.2012.0115","volume":"16","author":"R Melis","year":"2012","unstructured":"Melis R, Lewis T, Millson A, Lyon E, McMillin GA, Slev PR, et al. Copy number variation and incomplete linkage disequilibrium interfere with the HCP5 genotyping assay for abacavir hypersensitivity. Genet Test Mol Biomarkers. 2012;16(9):1111\u20134.","journal-title":"Genet Test Mol Biomarkers"},{"issue":"3","key":"11790_CR25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2217\/pgs.11.168","volume":"13","author":"C Badulli","year":"2012","unstructured":"Badulli C, Sestini R, Sbarsi I, Baroncelli M, Pizzochero C, Martinetti M, et al. Tag SNPs of the ancestral haplotype 57.1 do not substitute HLA-B* 57: 01 typing for eligibility to abacavir treatment in the Italian population. Pharmacogenomics. 2012;13(3):247\u20139.","journal-title":"Pharmacogenomics"},{"issue":"2","key":"11790_CR26","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/tpj.2014.48","volume":"15","author":"R Cascella","year":"2015","unstructured":"Cascella R, Strafella C, Ragazzo M, Zampatti S, Borgiani P, Gambardella S, Pirazzoli A, Novelli G, Giardina E. Direct PCR: a new Pharmacogenetic approach for the inexpensive testing of HLA-B* 57: 01. Pharmacogenomics J. 2015;15(2):196\u2013200.","journal-title":"Pharmacogenomics J"},{"issue":"1","key":"11790_CR27","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/cit665","volume":"58","author":"JA Aberg","year":"2014","unstructured":"Aberg JA, Gallant JE, Ghanem KG, Emmanuel P, Zingman BS, Horberg MA. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the infectious diseases society of America. Clin Infect Dis. 2014;58(1):e1\u201334.","journal-title":"Clin Infect Dis"},{"issue":"7263","key":"11790_CR28","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nature08365","volume":"461","author":"D Reich","year":"2009","unstructured":"Reich D, Thangaraj K, Patterson N, Price AL, Singh L. Reconstructing Indian population history. Nature. 2009;461(7263):489\u201394.","journal-title":"Nature"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11790-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11790-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11790-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T11:21:40Z","timestamp":1764242500000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11790-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11790"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11790-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"6 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the procedures were performed in compliance with relevant laws and approved by the ethical committee of the Institute of Medical Sciences, Banaras Hindu University, under Ethical Approval No. Dean\/2018\/EC\/860. Confidentiality and identity were maintained throughout the study. All the patients provided written consent before participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1668"}}